Researcher.Life Logo

Expert Review of Hematology : Impact Factor & More

eISSN: 1747-4094pISSN: 1747-4086

Aims and Scope of Expert Review of Hematology

Expert Review of Hematology is a MEDLINE-indexed, peer-reviewed, international medical journal publishing review articles and original papers on all aspects of hematology. It is part of the Expert Review series, published by Informa. Less

Key Metrics

CiteScore
4.2
H-Index
49
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.99
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Hematology

Expert Review of Hematology Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Hematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Hematology

Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways
  • 3 Jul 2026
  • Expert Review of Hematology
Apparent plateaus during iron chelation in transfusion-dependent β-thalassemia: interpretation and clinical implications
  • 3 Jul 2026
  • Expert Review of Hematology
Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think?
  • 3 Jun 2026
  • Expert Review of Hematology
Social challenges and support needs of patients with hemophilia in Pakistan: a qualitative exploratory study.
  • 18 May 2026
  • Expert review of hematology
Challenges faced by women and girls with hemophilia/Carriers: an expert call for closing the diagnosis gap
  • 15 May 2026
  • Expert Review of Hematology
Changes in circular RNA expression in acute chest syndrome and vaso-occlusive crisis in sickle cell disease: analysis of a public RNA-seq cohort
  • 11 May 2026
  • Expert Review of Hematology
Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways
  • 3 Jul 2026
  • Expert Review of Hematology
Apparent plateaus during iron chelation in transfusion-dependent β-thalassemia: interpretation and clinical implications
  • 3 Jul 2026
  • Expert Review of Hematology
Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think?
  • 3 Jun 2026
  • Expert Review of Hematology
Social challenges and support needs of patients with hemophilia in Pakistan: a qualitative exploratory study.
  • 18 May 2026
  • Expert review of hematology
Challenges faced by women and girls with hemophilia/Carriers: an expert call for closing the diagnosis gap
  • 15 May 2026
  • Expert Review of Hematology
Changes in circular RNA expression in acute chest syndrome and vaso-occlusive crisis in sickle cell disease: analysis of a public RNA-seq cohort
  • 11 May 2026
  • Expert Review of Hematology

FAQs on Expert Review of Hematology